Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
暂无分享,去创建一个
Brennan C Kahan | Rahul Bhatnagar | Nick A Maskell | Andrew R L Medford | N. Maskell | Y. C. Lee | A. Medford | B. Kahan | M. M. van den Heuvel | C. Tobin | J. Harvey | Y C Gary Lee | E. Fysh | C. Hooper | A. Morley | Clare E Hooper | Michel M van den Heuvel | Amelia O Clive | Anna J Morley | Natalie Zahan-Evans | Oliver J Bintcliffe | Rogier C Boshuizen | Edward T H Fysh | Claire L Tobin | John E Harvey | A. Clive | N. Zahan-Evans | R. Bhatnagar | O. Bintcliffe | R. Boshuizen | M. M. Heuvel | C. Hooper | Ce Hooper
[1] E. Scalzetti,et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. , 2005, Chest.
[2] M. Tattersall,et al. Management of malignant pleural effusions. , 1990, Thorax.
[3] Edmund Neville,et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.
[4] R. Ramakrishnan,et al. Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] D. Talwar,et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.
[6] G. Giaccone,et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] B. Kahan,et al. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis , 2012, BMJ : British Medical Journal.
[8] P Royston,et al. The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.
[9] M. Raza. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .
[10] J. Herndon,et al. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. , 1998, Chest.
[11] A. Giatromanolaki,et al. Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy , 2014, Respiration.
[12] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[13] J. Heffner,et al. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. , 2000, Chest.
[14] N. Pavlakis,et al. High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy , 2010, Clinical Cancer Research.
[15] A. Balci,et al. Predictors of mortality within three months in the patients with malignant pleural effusion. , 2010, European journal of internal medicine.
[16] R. Davies,et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.
[17] J. Aparicio,et al. Malignant Pleural Effusion: Prognostic Factors for Survival and Response to Chemical Pleurodesis in a Series of 120 Cases , 1998, Respiration.
[18] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[19] C. Sima,et al. Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients , 2011, Cancer Immunology, Immunotherapy.
[20] P. Goldstraw,et al. Management of malignant pleural effusions. , 2001, The European respiratory journal.
[21] P. Goldstraw,et al. Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural Effusion , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[22] T. Treasure,et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[23] J. Roth,et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. , 2000, The Annals of thoracic surgery.
[24] J. M. Porcel,et al. Prognostic significance of pleural fluid data in patients with malignant effusion. , 2008, European journal of internal medicine.
[25] Zhengwen Liu,et al. Prognostic role of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review and meta‐analysis , 2014, International journal of cancer.
[26] H. Colt,et al. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. , 2000, Chest.
[27] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .